Edition:
United States

Insider Trading: Biogen Inc (BIIB.O)

BIIB.O on Nasdaq

249.73USD
2:10pm EDT
Change (% chg)

$-0.36 (-0.14%)
Prev Close
$250.09
Open
$250.69
Day's High
$251.00
Day's Low
$249.01
Volume
858,913
Avg. Vol
1,649,427
52-wk High
$333.65
52-wk Low
$223.02

SHERWIN STEPHEN A

Institutional Holders

% Shares Owned: 90.54%
# of Holders: 1,430
Total Shares Held: 192,041,522
3 Mo. Net Change: -1,209,569
# New Positions: 87
# Closed Positions: 95
# Increased Positions: 552
# Reduced Positions: 543
# Net Buyers: 9

Officers & Directors

Name Age Since Current Position

Stelios Papadopoulos

68 2014 Independent Chairman of the Board

Michel Vounatsos

55 2017 Chief Executive Officer, Director

Paul Clancy

55 2007 Chief Financial Officer, Executive Vice President - Finance

Kenneth Di Pietro

58 2012 Executive Vice President - Human Resources

Susan Alexander

60 2011 Executive Vice President, Chief Legal Officer and Corporate Secretary

Michael Ehlers

48 2016 Executive Vice President, Head - Research and Development

Adriana Karaboutis

54 2014 Executive Vice President - Technology , Business Solutions and Corporate Affairs

Paul McKenzie

51 2016 Executive Vice President - Pharmaceutical Operations & Technology

Alfred Sandrock

59 2015 Executive Vice President - Neurology Discovery and Development and Chief Medical Officer

Anirvan Ghosh

2017 Senior Vice President - Research and Early Development

Gregory Covino

51 2012 Chief Accounting Officer, Vice President - Finance

Alexander Denner

47 2009 Independent Director

Caroline Dorsa

57 2010 Independent Director

Nancy Leaming

69 2008 Independent Director

Richard Mulligan

62 2009 Independent Director

Robert Pangia

66 1997 Independent Director

Brian Posner

55 2008 Independent Director

Eric Rowinsky

60 2010 Independent Director

Lynn Schenk

72 1995 Independent Director

Stephen Sherwin

68 2010 Independent Director